Real-time analysis of small-molecule metabolites such as ascorbic acid (AA), dopamine (DA), and uric acid (UA) is valuable for investigating biological systems and supporting disease diagnosis. As a representative metal-organic framework (MOF), MIL-101(Cr) combines strong chemical stability with a large specific surface area, demonstrating considerable potential in numerous fields. Herein, we demonstrated a series of polyoxometalate (POM)-incorporated bimetallic MOF composites, MIL-101(Cr2Fe)-POM-T (POM = SiW12 or PW12, T = 180 or 220), which were evaluated as electrochemical sensors for measuring AA, DA, and UA. Among them, MIL-101(Cr2Fe)-PW12-220 delivered the strongest electrochemical sensing response in 0.1 M PBS (pH = 7.0). After optimization, MIL-101(Cr2Fe)-PW12-220 demonstrated a broad linear detection range (412−6550, 1−160, and 2−160 μM) and low limits of detection (51.1, 0.385, and 0.644 μM, S/N = 3) when AA, DA, and UA were measured individually. In addition, MIL-101(Cr2Fe)-PW12-220 also enabled AA, DA, and UA analysis in human serum samples, supported by its broad linear range, low detection limits, selectivity, and stability.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: